우울증으로 내원한 진행성 핵상 마비 환자 1례
A Case of a Depressed Patient With Progressive Supranuclear Palsy
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Progressive supranuclear palsy (PSP) is rare atypical Parkinsonism accompanied by various psycho-behavioural problems. In this case report, we describe the diagnostic and treatment progress of a 65-year-old PSP patient who visited the psychiatric clinic with a depressed mood and lumbar pain resulting in a suicide attempt. Over the course of 30 months of treatment, typical characteristics of PSP, such as postural instability, dyskinesia, cognitive dysfunction and supranuclear gaze palsy, became prominent, and magnetic resonance imaging and the F-18 FP-CIT positron emission tomography revealed midbrain atrophy and reduced dopamine uptake in the basal ganglia. When treating elderly patients with depression, parkinsonism symptoms such as gait disturbances, frequent falls, tremors, and rigidity should be closely examined. (Anxiety and Mood 2023;19(2):56-60)
Abstract
Progressive supranuclear palsy (PSP) is rare atypical Parkinsonism accompanied by various psycho-behavioural problems. In this case report, we describe the diagnostic and treatment progress of a 65-year-old PSP patient who visited the psychiatric clinic with a depressed mood and lumbar pain resulting in a suicide attempt. Over the course of 30 months of treatment, typical characteristics of PSP, such as postural instability, dyskinesia, cognitive dysfunction and supranuclear gaze palsy, became prominent, and magnetic resonance imaging and the F-18 FP-CIT positron emission tomography revealed midbrain atrophy and reduced dopamine uptake in the basal ganglia. When treating elderly patients with depression, parkinsonism symptoms such as gait disturbances, frequent falls, tremors, and rigidity should be closely examined. (Anxiety and Mood 2023;19(2):56-60)
참고문헌 (15)
- Galts CPC, "Depression in neurodegenerative diseases : Common mechanisms and current treatment options", Neurosci Biobehav Rev, 102, pp.56~84 (2019)
- Barer Y, "Epidemiology of Progressive Supranuclear Palsy : Real World Data from the Second Largest Health Plan in Israel", Brain Sci, 12 (2022)
- Gerstenecker A, "Behavioral abnormalities in progressive supranuclear palsy", Psychiatry Res, 210, pp.1205~1210 (2013)
- Bloem BR, "Parkinson’s disease", Lancet, 397, pp.2284~2303 (2021)
- Veilleux Carpentier A, "Progressive supranuclear palsy : current approach and challenges to diagnosis and treatment", Curr Opin Neurol, 36, pp.309~316 (2023)
- Mueller C, "The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism", Parkinsonism Relat Disord, 54, pp.90~94 (2018)
- Litvan I, "Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy", Neurology, 57, pp.467~473 (2001)
- Tolosa E, "Challenges in the diagnosis of Parkinson’s disease", Lancet Neurol, 20, pp.385~397 (2021)
- Litvan I, "Clinical research criteria for the diagnosis of progressive supranuclear palsy(Steele-Richardson-Olszewski syndrome) : report of the NINDSSPSP international workshop", Neurology, 47, pp.1~9 (1996)
- 김원형, "Major Depressive Disorder Preceding the Onset of Progressive Supranuclear Palsy", PSYCHIATRY INVESTIGATION, 6(2), pp.112~114 (2009), 대한신경정신의학회
- Morgan JC, "Disease course and treatment patterns in progressive supranuclear palsy : A real-world study", J Neurol Sci, 421, pp.117293~ (2021)
- Hoglinger GU, "Clinical diagnosis of progressive supranuclear palsy : The movement disorder society criteria", Mov Disord, 32, pp.853~864 (2017)
- Boxer AL, "Advances in progressive supranuclear palsy : new diagnostic criteria, biomarkers, and therapeutic approaches", Lancet Neurol, 16, pp.552~563 (2017)
- Stamelou M, "A review of treatment options for progressive supranuclear palsy", CNS Drugs, 30, pp.629~636 (2016)
- Giagkou N, "Therapeutic management of the overlapping syndromes of atypical parkinsonism", CNS Drugs, 32, pp.827~837 (2018)